Nutraceutical

                   

Senesco to Present at the 4th International Symposium on Biocatalysis and Biotechnology (PR...

yahoo.com
1 hr ago 1 related
        

Senesco Technologies, Inc. announced today that Dr. John E. Thompson, Executive Vice President of Research and Development at Senesco, will present at the 4th International Symposium on Biocatalysis and Biotechnology , which is...

add comment
                   

Fullfill Satisfaction with Breast Enhancement Pills

turks.us
2 hrs ago 1 related
        

There are so much that people have been looking in terms of improving their overall physique, and you can’t blame them it is a part of who they are as an individual and as a person, really. While some women who find themselves...

add comment
                   

New pharmaceutical films with ultra-high moisture and oxygen barrier properties

pharmiweb.co.uk
yesterday 1 related
        

Klöckner Pentaplast, a leading producer of films for multiple packaging applications have extended their pharmaceutical film range, Pentapharm® to include Pentapharm® kpMax™ S04 films. Pentapharm® kpMax™ S04 films are...

add comment
                   

Interleukin Genetics' Heart Health Genetic Test a Tool for Identifying Patients with Heart Attack...

finanznachrichten.de
yesterday 2 related
        

WALTHAM, Mass., Nov. 17 /PRNewswire-FirstCall/ -- News that decreasing inflammation reduces the incidence of cardiovascular disease confirms the important contribution that Interleukin Genetics, Inc.'s , Heart Health Genetic...

add comment

BELLUS Health Announces Stock Listing Transfer From NASDAQ Global Market to NASDAQ Capital Market

redorbit.com
13-Nov-2008 4 related
        

Posted on: Thursday, 13 November 2008, 18:00 CST LAVAL, QC, Nov. 13 /PRNewswire-FirstCall/ -- BELLUS Health Inc. (NASDAQ: BLUS; TSX: BLU) announces today that it has received approval from the NASDAQ Listing Qualifications...

add comment

Korres Natural Products Group of Companies: Significant Increase in Sales by 52, 7% and by 29, 4%...

finanznachrichten.de
13-Nov-2008 2 related
        

ATHENS, November 13 /PRNewswire-FirstCall/ -- - Earnings After Taxes and Minority Rights (EAT&AM) Increased by 29, 4% to EUR3, 1m (from EUR2,4m in 9M 2007) In the first 9 months of 2008, Korres Natural Products Group of...

add comment

Forbes Medi-Tech Announces Third Quarter 2008 Financial Results

tmcnet.com
13-Nov-2008 2 related
        

VANCOUVER, BRITISH COLUMBIA, November 13 / MARKET WIRE/ -- Forbes Medi-Tech Inc. (TSX: FMI)(NASDAQ: FMTI) ("Forbes" or "Company") today announced its results for the third quarter ended September 30, 2008. The comparative...

add comment

Phosphagenics' diclofenac enters trial phase in humans

news-medical.net
13-Nov-2008 2 related
        

Phosphagenics Limited ("Phosphagenics") announced today that it has initiated a phase 1 human clinical trial using its patented drug delivery system, TPM, for the targeted delivery of a leading non steroidal anti-inflammatory...

add comment
                   

Cyanotech Reports Financial Results for the Second Quarter and First Six Months of Fiscal 2009...

yahoo.com
13-Nov-2008 204 related
        

KAILUA KONA, Hawaii----Cyanotech Corporation , a world leader in producing high-value nutrition and health products from microalgae, today announced financial results for the second quarter and first six months of fiscal 2009,...

add comment

BI Nutraceuticals' supplier gets NSF certification

bevnet.com
12-Nov-2008
        

Tagged Companies: BI Nutraceuticals LONG BEACH, Calif., November 12, 2008 --- BI Nutraceuticals today announced that its ginseng extract partner, Hongjiu Biotech, has been awarded NSF International Good Manufacturing Practices...

add comment
1 2 3 4 5 next »